PE-Backed Therapure Biopharma Delays $93M Canadian IPO
Private equity-backed biopharmaceutical company Therapure Biopharma said Thursday that it has postponed plans for a CA$130 million ($93.5 million) initial public offering in Canada because of shaky markets in the country...To view the full article, register now.
Already a subscriber? Click here to view full article